Matches in SemOpenAlex for { <https://semopenalex.org/work/W105763296> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W105763296 endingPage "71" @default.
- W105763296 startingPage "63" @default.
- W105763296 abstract "To study the prognostic value of the prostate-specific antigen (PSA) response and its relationship with other initial prognostic factors during the treatment of advanced prostatic carcinoma with total androgen blockade.Five hundred forty-six patients with advanced loco-regional (M0) or distant metastatic (M1) prostatic carcinoma treated with flutamide combined with either orchiectomy or LHRH analogues were included in this analysis. Initial patients characteristics and the PSA response were evaluated in relation to progression-free survival using a univariate and multivariate (Cox regression) analysis.The following prognostic factors were indicative of a decrease in progression-free survival: the absence of PSA normalization (< 4 ng/ml) after 3 or 6 months, M1 stage, high G grade, ECOG performance status > 1, presence of pain and absence of dysuria. In M1 patients the combination of PSA normalization after 3 or 6 months with initial G grade and ECOG performance status had the strongest predictive value.This study demonstrates that PSA normalization after 3 or 6 months along with initial tumor stage, grade and health status of the patient are the most important prognostic factors related to progression-free survival in the hormonal treatment of advanced prostatic carcinoma." @default.
- W105763296 created "2016-06-24" @default.
- W105763296 creator A5010015430 @default.
- W105763296 creator A5035487148 @default.
- W105763296 creator A5040722510 @default.
- W105763296 creator A5073799244 @default.
- W105763296 creator A5075342464 @default.
- W105763296 creator A5080730036 @default.
- W105763296 date "1997-10-01" @default.
- W105763296 modified "2023-09-23" @default.
- W105763296 title "PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients." @default.
- W105763296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9421938" @default.
- W105763296 hasPublicationYear "1997" @default.
- W105763296 type Work @default.
- W105763296 sameAs 105763296 @default.
- W105763296 citedByCount "12" @default.
- W105763296 countsByYear W1057632962016 @default.
- W105763296 crossrefType "journal-article" @default.
- W105763296 hasAuthorship W105763296A5010015430 @default.
- W105763296 hasAuthorship W105763296A5035487148 @default.
- W105763296 hasAuthorship W105763296A5040722510 @default.
- W105763296 hasAuthorship W105763296A5073799244 @default.
- W105763296 hasAuthorship W105763296A5075342464 @default.
- W105763296 hasAuthorship W105763296A5080730036 @default.
- W105763296 hasConcept C121608353 @default.
- W105763296 hasConcept C126322002 @default.
- W105763296 hasConcept C126894567 @default.
- W105763296 hasConcept C143998085 @default.
- W105763296 hasConcept C144301174 @default.
- W105763296 hasConcept C146357865 @default.
- W105763296 hasConcept C151730666 @default.
- W105763296 hasConcept C2776235491 @default.
- W105763296 hasConcept C2776845205 @default.
- W105763296 hasConcept C2777546739 @default.
- W105763296 hasConcept C2777911890 @default.
- W105763296 hasConcept C2778311097 @default.
- W105763296 hasConcept C2778313021 @default.
- W105763296 hasConcept C2780192828 @default.
- W105763296 hasConcept C2781406297 @default.
- W105763296 hasConcept C2781440318 @default.
- W105763296 hasConcept C38180746 @default.
- W105763296 hasConcept C50382708 @default.
- W105763296 hasConcept C61367390 @default.
- W105763296 hasConcept C71315377 @default.
- W105763296 hasConcept C71924100 @default.
- W105763296 hasConcept C77411442 @default.
- W105763296 hasConcept C86803240 @default.
- W105763296 hasConceptScore W105763296C121608353 @default.
- W105763296 hasConceptScore W105763296C126322002 @default.
- W105763296 hasConceptScore W105763296C126894567 @default.
- W105763296 hasConceptScore W105763296C143998085 @default.
- W105763296 hasConceptScore W105763296C144301174 @default.
- W105763296 hasConceptScore W105763296C146357865 @default.
- W105763296 hasConceptScore W105763296C151730666 @default.
- W105763296 hasConceptScore W105763296C2776235491 @default.
- W105763296 hasConceptScore W105763296C2776845205 @default.
- W105763296 hasConceptScore W105763296C2777546739 @default.
- W105763296 hasConceptScore W105763296C2777911890 @default.
- W105763296 hasConceptScore W105763296C2778311097 @default.
- W105763296 hasConceptScore W105763296C2778313021 @default.
- W105763296 hasConceptScore W105763296C2780192828 @default.
- W105763296 hasConceptScore W105763296C2781406297 @default.
- W105763296 hasConceptScore W105763296C2781440318 @default.
- W105763296 hasConceptScore W105763296C38180746 @default.
- W105763296 hasConceptScore W105763296C50382708 @default.
- W105763296 hasConceptScore W105763296C61367390 @default.
- W105763296 hasConceptScore W105763296C71315377 @default.
- W105763296 hasConceptScore W105763296C71924100 @default.
- W105763296 hasConceptScore W105763296C77411442 @default.
- W105763296 hasConceptScore W105763296C86803240 @default.
- W105763296 hasIssue "3" @default.
- W105763296 hasLocation W1057632961 @default.
- W105763296 hasOpenAccess W105763296 @default.
- W105763296 hasPrimaryLocation W1057632961 @default.
- W105763296 hasRelatedWork W2015488922 @default.
- W105763296 hasRelatedWork W2056416825 @default.
- W105763296 hasRelatedWork W2063216121 @default.
- W105763296 hasRelatedWork W2063655363 @default.
- W105763296 hasRelatedWork W2095742094 @default.
- W105763296 hasRelatedWork W2127440557 @default.
- W105763296 hasRelatedWork W2165488001 @default.
- W105763296 hasRelatedWork W2178139012 @default.
- W105763296 hasRelatedWork W2365391622 @default.
- W105763296 hasRelatedWork W83392053 @default.
- W105763296 hasVolume "65" @default.
- W105763296 isParatext "false" @default.
- W105763296 isRetracted "false" @default.
- W105763296 magId "105763296" @default.
- W105763296 workType "article" @default.